TL1A inhibitors in inflammatory bowel disease: A systematic review of phase 2 clinical trials
Fields of Study & Subjects
Immune Response and Inflammation
Inflammatory Bowel Disease
NF-κB Signaling Pathways
Publication details
- Journal / source
- Saudi Journal of Gastroenterology
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Volume
- 32
- Issue
- 5
- Pages
- 379–393
- Publication date
- 1 September 2026
- Language
- EN